Seidman Cancer Center
Showing of 84 results
Harrington Discovery Institute Researchers Identify New Drug Targets for Hard-to-Treat Cancers
New study of human cancers published in Science Signaling.
Dee and Jimmy Haslam Make $12.5 Million Transformational Investment in Blood Cancer Research and Treatments at University Hospitals
Benefiting patients worldwide, funding accelerates chronic lymphocytic leukemia research and rare cancer drug development through the Oxford-Harrington Rare Disease Centre and UH Seidman Cancer Center.
University Hospitals Now Offering New Therapy for Refractory Ventricular Tachycardia
Non-invasive stereotactic body radiation available at only a few select centers worldwide.
UH Seidman Cancer Center researchers to test a gut microbiome intervention as part of a cancer therapy regimen
The S2419 BioFront study is chaired by medical oncologist and Miggo Family Chair in Cancer Research, Pedro Barata, MD, M.Sc.
Researchers Develop Promising New Therapy for Most Common Form of Bone Cancer in Children and Young Adults
Study published in BMC Medicine.
Landmark Study Finds Limited Survival Benefit from Routine Hormone Therapy with Postoperative Radiation for Prostate Cancer
Research team led by UH Seidman Cancer Center and UCLA published results in The Lancet; Presented at the American Society of Clinical Oncology Genitourinary Symposium.
UH Seidman Cancer Center Researchers Find Real World Data Can Inform Care for Metastatic Castration-Resistant Prostate Cancer
Findings were published in JAMA Network Open.
UH Awarded Once Again for Exceptional Cardiovascular Care of Patients Undergoing Cancer Treatment
International Cardio-Oncology Society grants highest designation.